Our Board Members
Jean-Patrick Voisin, Essec, MBA | Chairman of the Board
As Chairman of the Board of OVVI Diagnostics, Jean-Patrick Voisin is also President of a Paris-based private financial holding company specialized in private equity investing, Concorde Capital. Since 1980, he has held various executive and board positions in industrial, health related and financial companies in France, Sweden, Asia and Eastern Europe. He graduated from ESSEC in 1977.
Hugues Wallemacq, Doctor of Veterinary Medicine, PhD, MBA │ Board Member
Hugues Wallemacq has broad experience in immunological and medical fields ranging from research and development to the commercialization of innovative vaccines and diagnostic applications. He is experienced in biotech, pharmaceuticals and innovation. Since 2020, Hugues works as an Investment Manager for Noshaq.
Daniel Bernard, HEC, MBA │ Board Member
As a « Capitaine d’industrie », Daniel Bernard is the former CEO of Carrefour and currently an investor at Provestis..
Robert Taub, BA RUCA University, MBA Insead │ Board Member
Robert Taub is a seasoned pharma/medtech entrepreneur and investor. He co-founded Octapharma in 1983 which he left in 1995. He also founded Omrix biopharmaceuticals in 1995, which was listed on NASDAQ in 2006 and sold to Johnson & Johnson in 2008. He was the chairman of NASDAQ listed Neuroderm Ltd. which was sold to Mitsubishi Tanabe in 2017. He co-founded Nyxoah S.A. in 2009.
Benoît Verjans, PhD, MBA ULB│ Board Member
Benoît Verjans is the CEO of OVVI Diagnostics. He has extensive experience in managing companies in the healthcare Industry such as Arlenda/PharmaLex, Auxin Surgery, ATC and Accessia Pharma. Previously he worked in large pharmaceutical companies like UCB and GSK Biologicals and also in management consulting at McKinsey & Co. He holds a PhD in biochemistry and a MBA, both from the Free University of Brussels (ULB).